Fortrea Holdings Inc.
FTRE
Rank in Stocks
#5752
Fortrea Holdings Inc. functions as a global contract research organization... Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Share Price
$22.24
Last synced: 2026-11-09
Market Cap
$2.10B
Change (1 day)
1.28%
Change (1 year)
88.63%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fortrea Holdings Inc. (FTRE)
Category
Healthcare
EPS for Fortrea Holdings Inc. (FTRE)
EPS as of September 2026 TTM: $-0.75
According to Fortrea Holdings Inc.'s latest financial reports, its current EPS (TTM) is $-0.75. At the end of 2025 the company had an EPS of $-10.81, a decrease compared to its 2024 EPS of $-3.67.
EPS history for Fortrea Holdings Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.75 | -93.06% |
| 2025 | $-10.81 | 194.55% |
| 2024 | $-3.67 | 9,075.00% |
| 2023 | $-0.04 | -101.90% |
| 2022 | $2.11 | 90.09% |
| 2021 | $1.11 | -127.34% |
| 2020 | $-4.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,188.00% |
US
|
|
| $-7.07 | 842.67% |
US
|
|
| $-5.29 | 605.33% |
AU
|
|
| $12.88 | -1,817.35% |
BE
|
|
| $21.56 | -2,974.67% |
NL
|
Questions about Fortrea Holdings Inc.'s earnings per share (EPS)
What is Fortrea Holdings Inc.'s earnings per share (EPS)?
Fortrea Holdings Inc.'s earnings per share (EPS) over the last twelve months is $-0.75, as of Sep 2026.
What was Fortrea Holdings Inc.'s earnings per share (EPS) in 2025?
In 2025, Fortrea Holdings Inc.'s earnings per share (EPS) was $-10.81, compared with $-3.67 in 2024.
How has Fortrea Holdings Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fortrea Holdings Inc.'s earnings per share (EPS) was highest in 2022 ($2.11) and lowest in 2025 ($-10.81).
How does Fortrea Holdings Inc.'s earnings per share (EPS) compare with similar companies?
Fortrea Holdings Inc.'s earnings per share (EPS) ($-0.75) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.